Key facts
- It has raised $1.1M; the latest was Later Stage VC in Jul 2025.
- Notable investors include MIT Solve, Khazanah Nasional, Gobi Partners, Kumpulan Modal Perdana.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for nanoSkunkWorkX
- ·The full record, as it builds
Funding rounds
No funding rounds for nanoSkunkWorkX are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About nanoSkunkWorkX
Developer of healthcare diagnostics, biosensors, energy storage, and advanced materials designed to bring nanotechnology to market. The company is involved in the design and development of a hybrid rapid test kit for detecting various diseases, including communicable and non-communicable diseases, providing users with a low-cost, sensitive, and faster option for diagnosis.
- Sector
- Healthcare
- HQ
- Kuala Lumpur, Malaysia
- Founded
- 2019
- Employees
- 9
- Website
- nanoskunkworkx.com/
- Ownership
- Privately Held (backing)
nanoSkunkWorkX doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in nanoSkunkWorkX shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on nanoSkunkWorkX in its N-PORT filings yet. We sweep new filings monthly.